25 agosto 2014
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to research. The ability to predict prognosis is critical to management of treatment. A patient with a good prognosis can be spared aggressive treatment, with its oft-unpleasant side effects. But failure to apply aggressive treatment to an aggressive tumor can lead to death.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/b1S3lnRJyJg/140825185834.htm
